Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Different Glycemic Index (GI) Values in 7 Food Products

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02278380
Recruitment Status : Completed
First Posted : October 30, 2014
Last Update Posted : April 13, 2015
Sponsor:
Information provided by (Responsible Party):
Danone Asia Pacific Holdings Pte, Ltd.

Brief Summary:
This study is initiated to investigate the glycemic index value of seven food products.

Condition or disease Intervention/treatment Phase
Glycemic Index Other: Low GI Standard Breakfast Other: Medium GI Standard Breakfast Other: Enfamama A+ Other: Glucerna Triple Care Other: Dumex Precima Other: Diasip Other: Test product Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: In-Vivo Glycemic Index (GI) and Insulinemic Index (II) Testing of 7 Test Foods in Total (5 Milk-based Beverage and 2 Standard Breakfast Items)
Study Start Date : June 2014
Actual Primary Completion Date : January 2015
Actual Study Completion Date : January 2015

Arm Intervention/treatment
Arm 1

To compare the Glycemic Index value of seven test foods:

Low GI standard Breakfast Medium GI standard Breakfast Nutritional pregnant milk supplement Nutritional product for diabetics Pregnant and lactation women milk powder Nutritional drinks for diabetics Test product

Other: Low GI Standard Breakfast
Low GI Standard Breakfast

Other: Medium GI Standard Breakfast
Medium GI Standard Breakfast

Other: Enfamama A+
Nutritional pregnant milk supplement

Other: Glucerna Triple Care
Nutritional product for diabetics

Other: Dumex Precima
Pregnant and lactation women milk powder

Other: Diasip
Nutritional drinks for diabetics

Other: Test product
Test product not patented yet
Other Name: Not patented yet, cannot disclose name.




Primary Outcome Measures :
  1. Glycemic index values of all seven products [ Time Frame: 120 minutes post administration ]
    Glycemic index values at 120 minutes post adminstration.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy males or non-pregnant females at least 6 weeks postpartum, non-lactating and aged 21-60yrs old in both groups.
  • They should not suffer from any chronic diseases.
  • no known food allergy or intolerance.
  • no medications known to affect glucose tolerance(excluding oral contraceptives). Note: stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.

Exclusion Criteria:

  • Age less than 21 years old and greater than 60 years old.
  • known history of diabetes mellitus or the use of antihyperglycemic drugs or insulin to treat diabetes and related conditions.
  • known history of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism.
  • subjects using any medication (eg steroids, protease inhibitors or antipsychotics, etc.) that would interfere with the digestion and nutrient absorption.,
  • subjects having gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism, excretion and have no known food allergies.
  • a major medical or surgical event requiring hospitalisation within the preceding 3 months.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02278380


Locations
Layout table for location information
Singapore
Temasek Polytechnic
Singapore, Singapore
Sponsors and Collaborators
Danone Asia Pacific Holdings Pte, Ltd.
Investigators
Layout table for investigator information
Principal Investigator: Kalpana Bhaskaran, Dr Temasek Polytechnic

Layout table for additonal information
Responsible Party: Danone Asia Pacific Holdings Pte, Ltd.
ClinicalTrials.gov Identifier: NCT02278380    
Other Study ID Numbers: GDM.1.C/D
First Posted: October 30, 2014    Key Record Dates
Last Update Posted: April 13, 2015
Last Verified: April 2015